PSNL Competitors & Alternatives
Compare Personalis Inc with similar stocks in the same industry
Diagnostics & Research
PSNL
Main Stock$10.06
Tradestie Score
54
Market Cap
$612.76M
Revenue Growth
-0.2%
Analyst Upside
+7.9%
Top Competitors
34 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GRAL
GRAIL, Inc. Common Stock
|
$61.11
|
$2.24B | - | 59 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$17.23
|
$2.22B | - | 55 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$85.00
|
$1.77B | - | 66 | Compare |
|
NEOG
Neogen Corp
|
$8.83
|
$1.26B | - | 49 | Compare |
|
OPK
Opko Health Inc.
|
$1.46
|
$1.23B | - | 56 | Compare |
|
NEO
NeoGenomics, Inc.
|
$11.47
|
$1.13B | - | 57 | Compare |
|
CDNA
CareDx, Inc.
|
$25.12
|
$798.40M | - | 66 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$18.18
|
$719.31M | - | 48 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$21.38
|
$667.77M | - | 62 | Compare |
|
ARCT
Arcturus Therapeutics Holdings Inc. Common Stock
|
$7.08
|
$556.12M | - | 56 | Compare |
More PSNL Analysis
Data updated: Jun 24, 2026 | Industry: Diagnostics & Research (SIC 8071)
34 stocks in this industry